Idarubicin 5 (Idarubicin Hydrochloride Vials) 5mg/5ml

Idarubicin Hydrochloride 5mg/5ml in 5ml vials is an anthracycline chemotherapy medication used for cancer treatment. This chemotherapy agent helps slow or stop cancer cell growth. Store at ambient temperature and handle with care.

Strength

5mg/5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Idarubicin Hydrochloride is primarily used to treat certain types of cancer, including leukemia and other malignancies. It may be prescribed when other treatments are not effective. This medication works by interfering with cancer cell DNA to reduce their growth. It is often used in combination with other chemotherapy drugs for better results.

Side Effects

Idarubicin Hydrochloride may cause temporary side effects such as nausea, hair loss, or fatigue. Some patients experience changes in urine color, which is normal. These effects vary by individual and are typically monitored by healthcare providers during treatment.

Precautions & Warnings

This medication should only be handled by trained professionals. Avoid direct contact with skin or eyes; use protective gear when preparing doses. Keep out of reach of children and pets. Report any unusual symptoms to a healthcare provider immediately.

Avoid Interactions

Idarubicin Hydrochloride may interact with other medications, including certain antibiotics, blood thinners, and heart medications. Alcohol and grapefruit products may also affect its action. Always inform your doctor about all medications and supplements you are taking before starting treatment.

Frequently Asked Questions

Idarubicin Hydrochloride is used to treat certain cancers, such as leukemia, by slowing or stopping cancer cell growth.

It is typically given as an intravenous injection by a healthcare professional in a clinical setting.

Common side effects may include nausea, hair loss, fatigue, and changes in urine color.

Consult your doctor before taking any other medications, as interactions may occur with certain drugs.

Store at ambient temperature, away from moisture and direct light, and keep out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.